Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-30

Clinical Trial Update: A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of 5% dapsone topical gel twice daily in combination with vehicle control, compared with adapalene gel 0.1% or benz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACZONE (DAPSONE)
  • DIFFERIN (ADAPALENE)
  • benzoyl peroxide gel 4% (benzoyl peroxide)

Snippet

Sponsor: Allergan | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED